Bioniche Life Sciences Inc. 25 Years
Contact Us Careers
Home Newsroom
In the News

August 25, 2010
Bioniche & University of Ottawa Sign Exclusive Global License Agreement for Natural Health Technology

August 20, 2010
Additional Phase III Clinical Trial with UrocidinTM Expected to Commence in 2010

Investors

Check latest
stock price

All prices delayed at least 15 minutes.
Source: TSX Inc.


Board of Directors

The composition of the Board of Directors reflects the Company's intent to have a majority of non-management Directors.

All Directors have a competence that contributes to the development of operating plans put forward by the company's management.

Non-Management Members
of the Board of Directors


Dr. Stan Alkemade
Dr. Armen Aprikian (Observer) 
Albert Beraldo
Margaret Cunningham
Pierre-Yves Desbiens
Dr. James Johnson
Nick Photiades
The Hon. Lyle Vanclief

Management Members
of the Board of Directors

Graeme McRae,
Chairman, President & CEO, Bioniche Life Sciences

Director Biographies

Dr. Stan Alkemade
Dr. Stan Alkemade received his veterinary degree from the University of Melbourne, Australia. He returned to Canada in 1971 and ran a mixed veterinary practice in Seaforth, Ontario for ten years. He has lectured in the Animal Health Technology program at the Centralia College of Agricultural Technology. In 1986, he joined Vetrepharm Canada Inc. as Technical Director and was responsible for research and development, product registrations, corporate technical services and facilities design. He is currently the President of BioMedEx, a project management firm for the pharmaceutical industry.

Top

Dr. Armen Aprikian (Observer)
Dr. Aprikian is Head of the Division of Urology, Department of Surgery, McGill University & Interim Chief of the Department of Oncology, McGill University Health Centre. He earned his Medical Degree at the University of Sherbrooke(Sherbrooke, Quebec) Faculty of Medicine and joined the Urology Training Program there upon graduating. He completed his residency at the McGill University Urology Residency Program (Montreal, Quebec) before attending Memorial Sloan-Kettering Cancer Center in New York. Dr. Aprikian subsequently joined the Department of Urology at the Montreal General Hospital as an Attending Surgeon. He served various academic and clinical roles in the Departments of Surgery (Division of Urology) and Oncology before becoming Head of the Division of Urology, Department of Surgery at McGill University and Interim Chief of the McGill University Health Centre’s Department of Oncology. His research has primarily focused on prostate and bladder cancers. Dr. Aprikian’s awards and honours include the Everett C. Reid Award for Excellence in Teaching, which he received on three occasions, the American Society of Clinical Oncology Investigator award. He was also named the McGill University William Dawson Scholar. He has been an invited lecturer locally, nationally and internationally and has held a number of Visiting Professorships.

Albert Beraldo
Mr. Beraldo is the President of Alveda Pharmaceuticals Inc., a privately –owned Canadian company that is a leading supplier of pharmaceuticals to the Canadian health care market. He formerly served as President & CEO of Bioniche Pharma Group Ltd. until 2005. He also served as Director of Bioniche Life Sciences Inc. from 1984 to 2005. Mr. Beraldo has a Bachelor of Commerce degree from the University of Windsor and has a Chartered Accountant designation from the Canadian Institute of Chartered Accountants. He worked in public accounting with Ernst and Whinney until he joined Vetrepharm as Financial Controller in 1983. Mr. Beraldo has held several positions within the group of companies which amalgamated to form Bioniche and played a major role in the formation of Bioniche Inc., one of the amalgamating companies.

Margaret Cunningham
Margaret Cunningham has a Ph.D. in marketing from Texas A&M University and an MBA from the University of Calgary. Dr. Cunningham is the Director of the School of Business, Associate Dean, and the R. A. Jodrey Chair in the Faculty of Management at Dalhousie University in Halifax, Nova Scotia. She is an award winning teacher and widely published author. She served as Associate Professor of Marketing at the School of Business at Queen’s University in Kingston, Ontario until late 2008. She had been a Professor in the School of Business at Queen’s since 1989.

Top

Pierre-Yves Desbiens
Mr. Desbiens is Vice President, Finance at PureCell Technologies Inc. He holds a Bachelor’s degree in Accounting from the University of Québec and an MBA from the Hautes Etudes Commerciales of the University of Montréal. Before joining PureCell Technologies, Mr. Desbiens held roles as Vice-President, Finance and Administration and Chief Financial Officer of Supratek Pharma Inc., Vice-President, Finance and Administration at Chronogen Inc., and Investment Portfolio Manager, Life Sciences, at the Québec Solidarity Fund QFL, a venture capital institutional investor in the Canadian life sciences sector. Prior to The Fund, Mr. Desbiens was Chief Financial Officer and General Manager of Horizon Sciences & Technologies Inc., a biopharmaceutical company based in Montréal. Before joining the health care sector, Mr. Desbiens held different positions in corporate finance with mid-size to multinational corporations, including Domtar Inc., Price Waterhouse, and Oceanix Inc. 

Dr. James Johnson
Dr. James Johnson has a doctorate in biochemistry in addition to his law degree, and is a partner of King & Spalding LLP based in Atlanta, Georgia. He has extensive experience in chemical and biotechnology patent prosecution and licensing.

Nick Photiades

Nick Photiades is currently a management and strategic planning consultant. In November, 2008, he retired after a long career with the Business Development Bank of Canada, where he was Senior Director, Life Sciences, Venture Capital Division. Mr. Photiades holds a Bachelor of Science degree in Physics from Concordia University and a Graduate Diploma in Management from McGill University. He has served as a director in several public and private high technology companies, mainly in the biotechnology area; he also served on the Board of Directors of the Chamber of Commerce of Metropolitan Montréal; and presently serves on the St. Mary’s Hospital Foundation Board.

The Hon. Lyle Vanclief
The Honourable Lyle Vanclief is former Minister of Agricultre and Agri-Food in the Government of Canada who is currently employed as an Agricultural and Agri-Food Consultant. He served as a Member of Parliament for the Government of Canada from 1988 to 2004. Throughout his political career, Mr. Vanclief held several parliamentary appointments, his most recent as Minister of Agriculture and Agri-Food. Prior to serving in public office, Mr. Vanclief previously spent 25 years as an agricultural entrepreneur in his home community of Ameliasburg, Ontario (Prince Edward County). He graduated with a Bachelor of Science degree in Agriculture from the University of Guelph in 1966. Mr. Vanclief is an Independent Director who will have key responsibilities for governance matters.

Top

Copyright 2004, Bioniche Life Sciences Inc. All rights reserved  |  Legal Disclaimer  |  Privacy Policy